Ceftaroline

INDICATIONS

FDA

  • Acute bacterial skin and skin structure infections (ABSSSIs)
  • Community acquired pneumonia (including cases caused by PCN-resistant S. pneumoniae)
    • Due to susceptible organisms: S. pneumoniae (including cases with bacteremia), MSSA, H. influenzae, K. pneumoniae, E. coli

NON-FDA APPROVED USES

  • MRSA infections not listed above

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: October 4, 2017